SCOTUS deals fresh blow to Novartis’ MS drug patent

18-04-2023

Liz Hockley

SCOTUS deals fresh blow to Novartis’ MS drug patent

Taljat David / Shutterstock.com

Petition to review invalidation of Gilenya patent denied | Novartis challenged decision resulting from a change in judicial panel.


Novartis, Gilenya, HEC Pharm, patent, Supreme Court

LSIPR